Skip to content

Shoulder Innovations Clinical Data Registry

Shoulder Innovations Clinical Data Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06754150
Acronym
SICDR
Enrollment
2500
Registered
2024-12-31
Start date
2024-10-23
Completion date
2039-12-01
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Arthroplasty

Keywords

Shoulder Arthroplasty, Shoulder Replacement, Anatomic Shoulder Arthroplasty, Reverse Shoulder Arthroplasty

Brief summary

The goal of this multi-center observational study is to collect long-term clinical outcome information for anatomic and reverse total shoulder arthroplasty (shoulder replacement).

Detailed description

The study is a non-randomized, multi-center prospective registry that will collect standard-of-care data for patients who plan to receive or have received shoulder arthroplasty (anatomic or reverse) with a Shoulder Innovations (SI) Total Shoulder System device and consent to participate in the study. The study will evaluate short and long term clinical and radiographic outcomes associated with real-world use of the arthroplasty system from the implant procedure through 10 years post-operatively.

Interventions

None listed

Sponsors

Shoulder Innovations
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. At least 18 years of age. 2. Plan to receive or has received a shoulder arthroplasty surgical procedure, with a minimum of one implanted Shoulder Innovations (SI) device component and be willing and able to complete post-operative visits as long as at least one SI device component remains implanted. 3. Able to provide informed consent prior to enrollment in the study (unless a waiver has been obtained). 4. Agree to and be able to consistently answer the specified Patient Reported Outcome Measures (PROM) pre-operatively and at each of the post-operative visits without the use of a translator. 5. Willing and able to comply with the requirements of the study protocol

Exclusion criteria

1. Participation in a clinical trial of an investigational drug or device that would confound the results of this trial. Participation in another observational registry is allowed provided there are no conflicting requirements to this trial. 2. Incarceration. 3. Any conditions, co-morbidities, restrictions, or obligations that would prohibit them from complying with the requirements of this study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Durability of the device component implantFrom the implant procedure until 10 years post-operativelyAssessment of the SI device component will be made at specified intervals using x-rays to check how long the device component can stay implanted with or without a revision surgery.

Secondary

MeasureTime frameDescription
Change in range of motion (ROM) post-operatively at specified timepoints as compared to baselineFrom baseline (pre-operatively) until 10 years post-operatively
Change in ASES score post-operatively at specified timepoints as compared to baselineFrom baseline (pre-operatively) until 10 years post-operativelyPatients will complete the ASES questionnaire (American Shoulder and Elbow Surgeons Shoulder Score) to evaluate pain and activities of daily living.
Change in SANE score post-operatively at specified timepoints as compared to baselineFrom baseline (pre-operatively) until 10 years post-operativelyPatients will complete the SANE questionnaire (Single Assessment Numeric Evaluation) to rate their affected shoulder as a percentage of normal.
Change in PROMIS Global-10 score post-operatively at specified timepoints as compared to baselineFrom baseline (per-operatively) until 10 years post-operativelyPatients will complete the PROMIS Global-10 questionnaire (Patient-Reported Outcome Measurement Information System Global-10) to evaluate pain and activities of daily living.
Evaluation of radiographic images for radiolucent lines, implant stability and looseningFrom baseline (pre-operatively) until 10 years post-operatively
Rate of intra-operative and post-operative adverse device effects (ADEs)/complicationsFrom the implant procedure until 10 years post-operatively

Countries

United States

Contacts

CONTACTAlyson Harris
alyson.harris@shoulderinnovations.com408-667-0535
CONTACTMichele La Badie
michele.labadie@shoulderinnovations.com615-603-8110

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 11, 2026